|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/745 | |
| A61K 38/36 | |||
| A61P 7/04 |
| (11) | Number of the document | 2147096 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08742852.0 |
| Date of filing the European patent application | 2008-04-11 | |
| (97) | Date of publication of the European application | 2010-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/004795 |
| Date | 2008-04-11 |
| (87) | Number | WO 2008/127702 |
| Date | 2008-10-23 |
| (30) | Number | Date | Country code |
| 923512 P | 2007-04-13 | US |
| (72) |
MADISON, Edwin, L., US
THANOS, Christopher, D., US
RUGGLES, Sandra, Waugh, US
COUGHLIN, Shaun, US
|
| (73) |
Catalyst Biosciences, Inc.,
260 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | Modified factor VII polypeptides and uses thereof |
| Modified factor VII polypeptides and uses thereof |